Computational modelling: Moonlighting on the neuroscience and medicine

Biomedical Reviews

Volumn 24, Issue , 2013, Pages 25-31

  Hassanzadeh, Parichehr ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biological system; Endocannabinoid system; Information processing; Nerve growth factor; Neural network

Indexed keywords

ENDOCANNABINOID; ION CHANNEL; NERVE GROWTH FACTOR;

ARTICLE; BEHAVIOR; BRAIN REGION; COGNITION; COMPUTER SIMULATION; DECISION MAKING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INFORMATION PROCESSING; MEDICINE; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROSCIENCE; ORBITAL CORTEX; PATHOPHYSIOLOGY; PROBLEM SOLVING; PSYCHOMETRY;

EID: 84949425461     PISSN: 1310392X     EISSN: 13141929     Source Type: Journal    
DOI: 10.14748/bmr.v24.19     Document Type: Article

References (68)

1. Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in Parkinsonism. Science (New York, N.Y.) 2007; 318: 1309-1312.
2. Moles CG, Mendes P, Banga JR. Parameter Estimation in biochemical pathways: a comparison of global optimization methods. Gen Res 2003; 13: 2467-2474.
3. Modolo J, Thomas AW, Legros A. Possible mechanisms of synaptic plasticity modulation by extremely lowfrequency magnetic fields. Electromagn Biol Med 2013; 32: 137-144.
4. Catterall WA, Raman IM, Robinson HP, Sejnowski TJ, Paulsen O. The Hodgkin-Huxley heritage: from channels to circuits. J Neurosci 2012; 32: 14064-14073.
5. O’Reilly RC, Herd SA, Pauli WM. Computational models of cognitive control. Curr opin Neurobiol 2010; 20: 257-261.
6. Dayan P. Simple substrates for complex cognition. Front Neurosci 2008; 2: 255-263.
7. Kotaleski JH, Blackwell KT. Modelling the molecular mechanisms of synaptic plasticity using systems biology approaches. Nat Rev Neurosci 2010; 11: 239-251.
8. Robinson PA, Rennie CJ, Rowe DL, O’Connor SC, Gordon E. Multiscale brain modelling. Philos Trans R Soc Lond B Biol Sci 2005; 360: 1043-1050.
9. Haeusler S, Maass W. A statistical analysis of informationprocessing of lamina-specific cortical microcircuit models. Cereb Cortex 2007; 17: 149-162.
10. Song D, Chan RH, Marmarelis VZ, Hampson RE, Deadwyler SA, Berger TW. Nonlinear modelling of neural population dynamics for hippocampal prostheses. Neural Netw 2009; 22: 1340-1351.
11. Chklovskii DB, Mel BW, Svoboda K. Cortical rewiring and information storage. Nature 2004; 431: 782-788.
12. Hassanzadeh, P, Ahmadiani A. Nitric oxide and c-Jun Nterminal kinase are involved in the development of dark neurons induced by inflammatory pain. Synapse 2006; 59: 101-106.
13. Aimone JB, Weik JP. Perspectives for computational modelling of cell replacement for neurological disorders. Front Comput Neurosci 2013; 7: 150.
14. Fusi S, Drew PJ, Abbott LF. Cascade models of synaptically stored memories. Neuron 2005; 45: 599-611.
15. Coggan JS, Bartol TM, Esquenazi E, Stiles JR, Lamont S, Martone ME, et al. Evidence for ectopic neurotransmission at a neuronal synapse. Science 2005; 309: 446-451.
16. Durstewitz D, Seamans JK, Sejnowski TJ. Neurocomputational models of working memory. Nat Neurosci 2000; 3: 1184-1191.
17. Ranganath C, Cohen MX, Dam C, D’Esposito M. Inferior temporal, prefrontal, an hippocampal contributions to visual working memory maintenance and associative memory retrieval. J Neurosci 2004; 24: 3917-3943.
18. Cottrell GW. New life for neural networks. Science 2006; 313: 454-455.
19. Tom SM, Fox CR, Trepel C, Poldrack RA. The neural basis of loss aversion in decision-making under risk. Science 2007; 315: 515-518.
20. Bogacz R. Optimal decision-making theories: linking neurobiology with behaviour. Trends Cogn Sci 2007; 11: 118-125.
21. Payzan-LeNestour E, Dunne S, Bossaerts P, O’Doherty JP. The neural representation of unexpected uncertainty during value-based decision making. Neuron 2013; 79: 191-201.
22. Hare T, Camerer C, Knoepfle D, O’Doherty J, Rangel A. Value computations in VMPFC during charitable decisionmaking incorporate input from regions involved in social cognition. J Neurosci 2010; 30: 583-590.
23. Hare T, Camerer C, Rangel A. Self-control in decisionmaking involves modulation of the MPFC valuation system. Science 2009; 324: 646-648.
24. Koechlin E, Summerfield C. An information theoretical approach to prefrontal executive function. Trends Cogn Sci 2007; 11: 229-235.
25. Erickson DT, Kayser AS. The neural representation of sensorimotor transformations in a human perceptual decision making network. Neuroimage 2013; 79: 340-350.
26. Machens CK, Romo R, Brody CD. Flexible control of mutual inhibition: a neural model of two-interval discrimination. Science 2005; 307: 1121-1124.
27. Chatham CH, Frank MJ, Munakata Y. Pupillometric and behavioral markers of a developmental shift in the temporal dynamics of cognitive control. Proc Nat Acad Sci USA 2009; 106: 5529-5533.
28. Levi-Montalcini R. The nerve growth factors 35 years later. Science 1987; 237: 1154-1162.
29. Triaca V. Homage to Rita Levi-Montalcini. Molecular mechanisms of Alzheimer’s disease: NGF modulation of APP processing. Adipobiology 2013; 5:1-12.
30. Hassanzadeh P, Hassanzadeh A. Implication of NGF and endocannabinoid signalling in the mechanism of action of sesamol: a multi-target natural compound with therapeutic potential. Psychopharmacology 2013; 229: 571-578.
31. Hassanzadeh P, Rahimpour S. The cannabinergic system is implicated in the upregulation of central NGF protein by psychotropic drugs. Psychopharmacology 2011; 215: 129-141.
32. Hassanzadeh P, Hassanzadeh A. Involvement of the neurotrophin and cannabinoid systems in the mechanisms of action of neurokinin receptor antagonists. Eur Neuropsychopharmcol 2011; 21: 905-917.
33. Hassanzadeh P, Hassanzadeh A. The CB1 Receptor-Mediated Endocannabinoid Signalling and NGF: The Novel Targets of Curcumin. Neurochem Res 2012; 37: 1112-1120.
34. Hassanzadeh P, Hassanzadeh A. Effects of different psychotropic agents on the central nerve growth factor protein. Iran J Basic Med Sci 2010; 13: 202-209.
35. Bianchi P, Rocco ML, De Bellis A, Aloe L. Effect of intranasal NGF administration in injured spinal cord and leptin levels in adult rats. Adipobiology 2012; 4:-67-75.
36. Yanev S, Aloe L, Fiore F, Chaldakov GN. Neurotrophic and metabotrophic potential of nerve growthfactor and brain-derived neurotrophic factor: Linking cardiometabolic and neuropsychiatric diseases. World J Pharmacol 2013; 2: 92-99.
37. Kurakhmaeva KB, Djindjikhashvili IA, Petrov VE, Balabanyan VU, Voronina TA, Trofimov SS, et al. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles. J Drug Target 2009; 17: 564-574.
38. Brown KS, Hill CC, Caleor GA, Myers CR, Lee KH, Sethna JP, et al. The statistical mechanics of complex signalling networks: nerve growth factor signalling. Phys Biol 2004; 1: 184-195.
39. Groot M, Boxer LM, Thiel G. Nerve growth factor-and epidermal growth factor-regulated gene transcription in PC12 pheochromocytoma and INS-1 insulinoma cells. Eur J Cell Biol 2000; 79: 924-935.
40. Hassanzadeh P. The endocannabinoid system: critical for the neurotrophic action of psychotropic drugs. BioMed Rev 2010; 21: 31-46.
41. Hassanzadeh P, Hassanzadeh A. The role of the endocannabinoids in suppression of the HPA axis activity by doxepin. Iran J Basic Med Sci 2011; 14: 414-421.
42. Marsicano G, Lutz B. Neuromodulatory functions of the endocannabinoid system. J Endocrinol Investig 2006; 29: 27-46.
43. Boger DL, Henriksen SJ, Cravatt BF. Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signalling molecules. Curr Pharm Des 1998; 4: 303-314.
44. Kim D, Thayer SA. Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture. J Neurosci 2001; 21: RC146.
45. Wilson RI, Kunos G, Nicoll RA. Presynaptic specificity of endocannabinoid signalling in the hippocampus. Neuron 2001; 31: 453-462.
46. Fernández-Ruiz JJ, Berrendero F, Hernández ML, Ramos JA. The endogenous cannabinoid system and brain development. Trends Neurosci 2000; 23: 14-20.
47. Richard Piet, André Garenne, Fanny Farrugia, Gwendal Le Masson, Giovanni Marsicano, Pascale Chavis, Olivier J Manzoni. State-dependent, bidirectional modulation of neural network activity by endocannabinoids. J Neurosci 2011; 31: 16591-16596.
48. Keimpema E, Mackie K, Harkany T, 2011. Molecular model of cannabis sensitivity in developing neuronal circuitries. Trends Pharmacol Sci 32: 551-561.
49. Murillo-Rodriguez E, Sanchez-Alavez M, Navarro L, Martinez-Gonzalez D, Drucker-Colin R, Prospero-Garcia O. Anandamide modulates sleep and memory in rats. Brain Res 1998; 812: 270-274.
50. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, et al. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 2001; 21: 9506-9518.
51. Godin B, Tasciotti E, Liu X, Serda RE, Ferrari M. Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics. Acc Chem Res 2011; 44: 979-989.
52. Walenga RL, Tian G, Longest PW. Development of characteristic upper tracheobronchial airway models for testing pharmaceutical aerosol delivery. J Biomech Eng 2013; 135: 91010.
53. Yamanishi Y, Pauwels E, Kotera M. Drug side-effect prediction based on the integration of chemical and biological spaces. J Chem Inf Model 2012; 52: 3284-3292.
54. Sarem M, Moztarzadeh F, Mozafari M, Shastri VP. Optimization strategies on the structural modelling of gelatin/ chitosan scaffolds to mimic human meniscus tissue. Mater Sci Eng C Mater Biol Appl 2013; 33: 4777-4785.
55. Han Z, Sui X, Zhou D, Zhou C, Ren Q. Biomechanical and refractive behaviors of keratoconic cornea based on three-dimensional anisotropic hyperelastic models. J Refract Surg 2013; 29: 282-290.
56. Castelli M, Cappelletti F, Diotti RA, Sautto G, Criscuolo E, Dal Peraro M, et al. Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. Clin Dev Immunol 2013; 2013: 521231.
57. Georgakarakos E, Xenakis A, Manopoulos C, Georgiadis GS, Tsangaris S, Lazarides M. Geometric factors affecting the displacement forces in an aortic endograft with crossed limbs: a computational study. J Endovasc Ther 2013; 20: 191-199.
58. Heifetz A, Baker O, Verquin G, Wimmer N, Meutermans W, Pal S, et al. Fighting obesity with a sugar-based library: discovery of novel MCH-1R antagonists by a new computational-VAST approach for exploration of GPCR binding sites. J Chem Inf Model 2013;53:1084-1099.
59. Castiglione F, Tieri P, De Graaf A, Franceschi C, Lio P, Van Ommen B, et al. The onset of type 2 diabetes: proposal for a multi-scale model. JMIR Res Protoc 2013;2:e44. doi: 10.2196/resprot.2854.
60. Taylor CA, Fonte TA, Min JK. Computational fluid dynamics applied to cardiac computed tomography for noninvasive quantification of fractional flow reserve: scientific basis. J Am Coll Cardiol 2013; 61: 2233-2241.
61. Hariharan P, Freed M, Myers MR. Use of computational fluid dynamics in the design of dynamic contrast enhanced imaging phantoms. Phys Med Biol 2013; 58: 6369-6391.
62. Friston KJ. Modalities, modes, and models in functional neuroimaging. Science 2009; 326: 399-403.
63. Hassanzadeh P. New perspectives in biosensor technology. Gastroenterol Hepatol Bed Bench 2010; 3: 105-107.
64. Hassanzadeh P, Fullwood I, Sothi S, Aldulaimi D. Cancer nanotechnology. Gastroenterol Hepatol Bed Bench 2011; 4: 63-69.
65. Malhotra BD, Chaubey A. Biosensors for clinical diagnostics industry. J Sensors Actuat B-Chem 2003; 91: 117-127.
66. Yu D, Blankert B, Viré JC, Kauffmann JM. Biosensors in drug discovery and drug analysis. Anal Lett 2005; 38: 1687-1701.
67. Schulmeister T, Pfeiffer D. Mathematical modelling of amperometric enzyme electrodes with perforated membranes. Biosens Bioelectron 1993; 8: 75-79.
68. Baronas R, Kulys J, Ivanauskas F. Computational modelling of biosensors with perforated and selective membranes. J Math Chem 2006; 39: 345-362.